JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: Finally, we found no clear correlation between the mutational burden of the JAK2 mutation and the BCR::ABL1 transcript levels at the time of CML diagnosis and during treatment of CML with TKI.